Clonotypic characterization defines B‐cell drivers of clonal expansion and intratumor heterogeneity in IgM monoclonal gammopathies

Study limitation reported by the research below: “CD9 expression as a tumor marker was absent in some relapsed/refractory and previously treated patients, limiting its universality as a biomarker.”